Cargando…

Application of LpxC enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics

BACKGROUND: Culturomics can ascertain traces of microorganisms to be cultivated using different strategies and identified by matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry or 16S rDNA sequencing. However, to cater to all requirements of microorganisms and isolate as man...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Fengyi, Chang, Yuxiao, Huang, Zongyu, Han, Ni, Bin, Lei, Deng, Huimin, Li, Zhengchao, Pan, Zhiyuan, Ding, Lei, Gao, Hong, Yang, Ruifu, Zhi, Fachao, Bi, Yujing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937742/
https://www.ncbi.nlm.nih.gov/pubmed/31888576
http://dx.doi.org/10.1186/s12866-019-1681-6
_version_ 1783483925172060160
author Hou, Fengyi
Chang, Yuxiao
Huang, Zongyu
Han, Ni
Bin, Lei
Deng, Huimin
Li, Zhengchao
Pan, Zhiyuan
Ding, Lei
Gao, Hong
Yang, Ruifu
Zhi, Fachao
Bi, Yujing
author_facet Hou, Fengyi
Chang, Yuxiao
Huang, Zongyu
Han, Ni
Bin, Lei
Deng, Huimin
Li, Zhengchao
Pan, Zhiyuan
Ding, Lei
Gao, Hong
Yang, Ruifu
Zhi, Fachao
Bi, Yujing
author_sort Hou, Fengyi
collection PubMed
description BACKGROUND: Culturomics can ascertain traces of microorganisms to be cultivated using different strategies and identified by matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry or 16S rDNA sequencing. However, to cater to all requirements of microorganisms and isolate as many species as possible, multiple culture conditions must be used, imposing a heavy workload. In addition, the fast-growing bacteria (e.g., Escherichia) surpass the slow-growing bacteria in culture by occupying space and using up nutrients. Besides, some bacteria (e.g., Pseudomonas) suppress others by secreting antibacterial metabolites, making it difficult to isolate bacteria with lower competence. Applying inhibitors to restrain fast-growing bacteria is one method to cultivate more bacterial species from human feces. RESULTS: We applied CHIR-090, an LpxC enzyme inhibitor that has antibacterial activity against most Gram-negative bacteria, to culturomics of human fresh feces. The antibacterial activity of CHIR-090 was first assessed on five Gram-negative species of bacteria (Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus vulgaris, and Bacteroides vulgatus), all of which are commonly isolated from the human gut. Then, we assessed suitable concentrations of the inhibitor. Finally, CHIR-090 was applied in blood culture bottles for bacterial cultivation. In total, 102 species from five samples were identified. Of these, we found one new species, two species not reported previously in the human gut, and 11 species not previously isolated from humans. CONCLUSIONS: CHIR-090 can suppress E. coli, P. aeruginosa, K. pneumoniae, Pro. vulgaris, but not B. vulgatus. Compared with the non-inhibitor group, CHIR-090 increased bacteria isolation by 23.50%, including four species not reported in humans and one new species. Application of LpxC enzyme inhibitor in culturomics increased the number of species isolated from the human gut.
format Online
Article
Text
id pubmed-6937742
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69377422019-12-31 Application of LpxC enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics Hou, Fengyi Chang, Yuxiao Huang, Zongyu Han, Ni Bin, Lei Deng, Huimin Li, Zhengchao Pan, Zhiyuan Ding, Lei Gao, Hong Yang, Ruifu Zhi, Fachao Bi, Yujing BMC Microbiol Research Article BACKGROUND: Culturomics can ascertain traces of microorganisms to be cultivated using different strategies and identified by matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry or 16S rDNA sequencing. However, to cater to all requirements of microorganisms and isolate as many species as possible, multiple culture conditions must be used, imposing a heavy workload. In addition, the fast-growing bacteria (e.g., Escherichia) surpass the slow-growing bacteria in culture by occupying space and using up nutrients. Besides, some bacteria (e.g., Pseudomonas) suppress others by secreting antibacterial metabolites, making it difficult to isolate bacteria with lower competence. Applying inhibitors to restrain fast-growing bacteria is one method to cultivate more bacterial species from human feces. RESULTS: We applied CHIR-090, an LpxC enzyme inhibitor that has antibacterial activity against most Gram-negative bacteria, to culturomics of human fresh feces. The antibacterial activity of CHIR-090 was first assessed on five Gram-negative species of bacteria (Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Proteus vulgaris, and Bacteroides vulgatus), all of which are commonly isolated from the human gut. Then, we assessed suitable concentrations of the inhibitor. Finally, CHIR-090 was applied in blood culture bottles for bacterial cultivation. In total, 102 species from five samples were identified. Of these, we found one new species, two species not reported previously in the human gut, and 11 species not previously isolated from humans. CONCLUSIONS: CHIR-090 can suppress E. coli, P. aeruginosa, K. pneumoniae, Pro. vulgaris, but not B. vulgatus. Compared with the non-inhibitor group, CHIR-090 increased bacteria isolation by 23.50%, including four species not reported in humans and one new species. Application of LpxC enzyme inhibitor in culturomics increased the number of species isolated from the human gut. BioMed Central 2019-12-30 /pmc/articles/PMC6937742/ /pubmed/31888576 http://dx.doi.org/10.1186/s12866-019-1681-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hou, Fengyi
Chang, Yuxiao
Huang, Zongyu
Han, Ni
Bin, Lei
Deng, Huimin
Li, Zhengchao
Pan, Zhiyuan
Ding, Lei
Gao, Hong
Yang, Ruifu
Zhi, Fachao
Bi, Yujing
Application of LpxC enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics
title Application of LpxC enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics
title_full Application of LpxC enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics
title_fullStr Application of LpxC enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics
title_full_unstemmed Application of LpxC enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics
title_short Application of LpxC enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics
title_sort application of lpxc enzyme inhibitor to inhibit some fast-growing bacteria in human gut bacterial culturomics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937742/
https://www.ncbi.nlm.nih.gov/pubmed/31888576
http://dx.doi.org/10.1186/s12866-019-1681-6
work_keys_str_mv AT houfengyi applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT changyuxiao applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT huangzongyu applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT hanni applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT binlei applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT denghuimin applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT lizhengchao applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT panzhiyuan applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT dinglei applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT gaohong applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT yangruifu applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT zhifachao applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics
AT biyujing applicationoflpxcenzymeinhibitortoinhibitsomefastgrowingbacteriainhumangutbacterialculturomics